Comparison of Different Promoter Methylation Assays in Breast Cancer

Background: Promoter hypermethylation has emerged as a promising cancer biomarker. Currently, a large variety of quantitative and non-quantitative techniques is used to measure methylation in clinical specimens. Here we directly compared three commonly used methylation assays and assessed the influe...

Full description

Bibliographic Details
Main Authors: Karijn P. M. Suijkerbuijk, Xiaojuan Pan, Elsken van der Wall, Paul J. van Diest, Marc Vooijs
Format: Article
Language:English
Published: Hindawi Limited 2010-01-01
Series:Analytical Cellular Pathology
Online Access:http://dx.doi.org/10.3233/ACP-CLO-2010-0542
Description
Summary:Background: Promoter hypermethylation has emerged as a promising cancer biomarker. Currently, a large variety of quantitative and non-quantitative techniques is used to measure methylation in clinical specimens. Here we directly compared three commonly used methylation assays and assessed the influence of tissue fixation, target sequence location and the amount of DNA on their performance.
ISSN:2210-7177
2210-7185